egtazic acid has been researched along with Carcinoma, Medullary in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Komitowska, J; Raue, F; Zink-Lorenz, A | 1 |
1 other study(ies) available for egtazic acid and Carcinoma, Medullary
Article | Year |
---|---|
Norepinephrine induced calcitonin secretion in rat medullary thyroid carcinoma 6-23 cells: interaction between intracellular calcium and cAMP.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Calcitonin; Calcium; Calcium Channel Blockers; Carcinoma, Medullary; Cell Line; Cyclic AMP; Cytosol; Dose-Response Relationship, Drug; Egtazic Acid; Kinetics; Norepinephrine; Phentolamine; Phenylisopropyladenosine; Rats; Thyroid Neoplasms; Tumor Cells, Cultured; Verapamil | 1996 |